HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The Association between Cytokines and 365-Day Readmission or Mortality in Adult Cardiac Surgery.

Abstract
Cardiac surgery results in a multifactorial systemic inflammatory response with inflammatory cytokines, such as interleukin-10 and 6 (IL-10 and IL-6), shown to have potential in the prediction of adverse outcomes including readmission or mortality. This study sought to measure the association between IL-6 and IL-10 levels and 1-year hospital readmission or mortality following cardiac surgery. Plasma biomarkers IL-6 and IL-10 were measured in 1,047 patients discharged alive after isolated coronary artery bypass graft surgery from eight medical centers participating in the Northern New England Cardiovascular Disease Study Group between 2004 and 2007. Readmission status and mortality were ascertained using Medicare, state all-payer claims, and the National Death Index. We evaluated the association between preoperative and postoperative cytokines and 1-year readmission or mortality using Kaplan-Meier estimates and Cox's proportional hazards modeling, adjusting for covariates used in the Society of Thoracic Surgeons 30-day readmission model. The median follow-up time was 1 year. After adjustment, patients in the highest tertile of postoperative IL-6 values had a significantly increased risk of readmission or death within 1 year (HR: 1.38; 95% CI: 1.03-1.85), and an increased risk of death within 1 year of discharge (HR: 4.88; 95% CI: 1.26-18.85) compared with patients in the lowest tertile. However, postoperative IL-10 levels, although increasing through tertiles, were not found to be significantly associated independently with 1-year readmission or mortality (HR: 1.25; 95% CI: .93-1.69). Pro-inflammatory cytokine IL-6 and anti-inflammatory cytokine IL-10 may be postoperative markers of cardiac injury, and IL-6, specifically, shows promise in predicting readmission and mortality following cardiac surgery.
AuthorsAllen D Everett, Shama S Alam, Sherry L Owens, Devin M Parker, Christine Goodrich, Donald S Likosky, Heather Thiessen-Philbrook, Moritz Wyler von Ballmoos, Kevin Lobdell, Todd A MacKenzie, Jeffrey Jacobs, Chirag R Parikh, Anthony W DiScipio, David J Malenka, Jeremiah R Brown
JournalThe journal of extra-corporeal technology (J Extra Corpor Technol) Vol. 51 Issue 4 Pg. 201-209 (Dec 2019) ISSN: 0022-1058 [Print] France
PMID31915403 (Publication Type: Journal Article)
Copyright© Copyright 2019 AMSECT.
Chemical References
  • Cytokines
Topics
  • Cardiac Surgical Procedures
  • Cytokines
  • Female
  • Humans
  • Medicare
  • Patient Readmission
  • Risk Factors
  • United States

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: